Sat, 11 Jul 2026

November 23, 2022

people moves

Hong Kong-based Immuno Cure BioTech names new CFO

FutureCFO Editors November 23, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies,

Recent posts

APAC business travellers bend company T&E policies, study finds

Singapore CFOs remain confident outlook for their own business

Allianz Trade partners with Mastercard for B2B travel payments

The CFO’s blueprint for autonomous finance in ASEAN

Philippines’ tax watchdog renews partnership with business groups

Study: Gap between sustainability understanding, quantifying financial value

Subscribe